Effectiveness of Sotalol as First-Line Therapy for Fetal Supraventricular Tachyarrhythmias
Authors:
- Anita Moon-GradyAMAnita Moon-Grady
- Neil BhogalNBNeil Bhogal
- Kathryn K. CollinsKCKathryn K. Collins
- Theresa TacyTTTheresa Tacy
- Michael BrookMBMichael Brook
- Lisa K. HornbergerLHLisa K. Hornberger
- 1 June 2012
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 109 (11) , 1614-1618
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Echocardiographic assessment of fetal arrhythmiasHeart, 2007
- Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordingsHeart, 2003
- Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamicsJACC, 2003
- Review of diagnosis, treatment, and outcome of fetal atrial flutter compared with supraventricular tachycardiaHeart, 2003
- Drug Treatment of Fetal TachycardiasPediatric Drugs, 2002
- Sotalol in the Treatment of Fetal DysrhythmiasCirculation, 2000
- Atrial flutter in the perinatal age group: diagnosis, management and outcomeJACC, 2000
- Foetal supraventricular tachycardia treated with sotalolActa Paediatrica, 1998
- Fetal atrial flutter: Diagnosis, clinical features, treatment, and outcomeThe Journal of Pediatrics, 1998
- Fetal tachycardia: Mechanisms and predictors of hydrops fetalisJACC, 1996